Australia Medical Device Clinical Trials Market Size & Outlook
The medical device clinical trials market in Australia is expected to reach a projected revenue of US$ 317.9 million by 2030. A compound annual growth rate of 4% is expected of Australia medical device clinical trials market from 2025 to 2030.
Australia medical device clinical trials market highlights
The Australia medical device clinical trials market generated a revenue of USD 254.4 million in 2024 and is expected to reach USD 317.9 million by 2030.
The Australia market is expected to grow at a CAGR of 4% from 2025 to 2030.
In terms of segment, pivotal study was the largest revenue generating study type in 2024.
Pivotal Study is the most lucrative study type segment registering the fastest growth during the forecast period.
Medical device clinical trials market data book summary
Market revenue in 2024
USD 254.4 million
Market revenue in 2030
USD 317.9 million
Growth rate
4% (CAGR from 2025 to 2030)
Largest segment
Pivotal study
Fastest growing segment
Pivotal Study
Historical data
2018 - 2023
Base year
2024
Forecast period
2025 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Feasibility and Pilot Study, Pivotal Study, FDA PMA Application, Post-Approval Study
Other key industry trends
In terms of revenue, Australia accounted for 1.5% of the global medical device clinical trials market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China medical device clinical trials market is projected to lead the regional market in terms of revenue in 2030.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,647.0 million by 2030.
Australia Medical Device Clinical Trials Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Medical Device Clinical Trials Market Outlook will help companies and investors design strategic landscapes.
Pivotal Study was the largest segment with a revenue share of 42.37% in 2024.
Horizon Databook has segmented the Australia medical device clinical trials market based on feasibility and pilot study, pivotal study, fda pma application, post-approval study covering the revenue growth of each sub-segment from 2018 to 2030.
Australia Medical Device Clinical Trials Market Study Type Outlook (Revenue, USD Million , 2018-2030)
Feasibility and Pilot Study
Pivotal Study
FDA PMA Application
Post-Approval Study
Australia Medical Device Clinical Trials Market Study Design Outlook (Revenue, USD Million , 2018-2030)
Interventional
Observational
Expanded Access
Australia Medical Device Clinical Trials Market Indication Outlook (Revenue, USD Million , 2018-2030)
Cardiovascular devices
Neurology devices
Orthopedic devices
Diagnostic imaging
Anesthesia and Respiratory devices
Others
Reasons to subscribe to Medical Device Clinical Trials Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Medical Device Clinical Trials Market Outlook databook
Our clientele includes a mix of Medical Device Clinical Trials Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Medical Device Clinical Trials Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Medical Device Clinical Trials Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Australia Medical Device Clinical Trials Market, 2018-2030 (US$M)